Lv4
480 积分 2026-06-12 加入
Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
1天前
待确认
Hepatic antifibrotic response by fibrogenesis markers in in patients with MASLD undergoing a 6-month randomized dietary trial
2天前
已关闭
Thrombospondin-2: a promising but unproven biomarker for MASH
4天前
已完结
Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease
1个月前
已完结
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
1个月前
已完结
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
2个月前
已完结
Serum thrombospondin-2 as a non-invasive biomarker for liver fibrosis in chronic hepatitis B
2个月前
已完结
Metabolic Derangement in Non-Alcoholic Fatty Liver Disease: Opportunities for Early Diagnostic and Prognostic Markers
2个月前
已完结
Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease
2个月前
已完结
皖公网安备34019202002308
